In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers.
CEO at Y-mabs Claus Møller sees the potential to create "the Tesla within biotechnology" in the Danish-American cancer company, as reported by Danish media Børsen.
Hearing aid manufacturer Sonova says direct contact with consumers on the growing Chinese market will be the way forward to increase growth.
German 4teen4 has chosen AGC Biologics as contract developer for the clinical testing of its drug candidate, procizumab.
The European Medicines Agency will assess the potential vaccine being developed by Valneva as data trickles in.
An Australian media has indicated that CSL is in talks to acquire Swiss Vifor Pharma, a competitor to Pharmacosmos, which is based in Denmark.
It is appropriate to consider obligatory Covid-19 jabs, says EU Commission President Ursula von der Leyen.
Four months into Jesper Brandgaard's tenure as chairman of the board at Leo Pharma, CEO Catherine Mazzacco is stepping down. Now, the hunt for a new CEO to take the company through an initial public offering process begins.
It was a mistake to hire Catherine Mazzacco as CEO of Leo Pharma, says a headhunter focused on the pharmaceutical industry, who predicts that the board will look internationally to find her replacement.
Kesimpta has not blown the council away, a draft assessment of the Genmab-developed drug's clinical value suggests.
Medtech company Coloplast has started a new clinical trial to test the effect of its ostomy product, Heylo, a product which uses sensors to warn patients with colostomy bags about leakage and advise them about how to prevent it.
A new network of reference laboratories, which are part of the disease prevention efforts in the region, will pave the way for better data on future pandemics, a spokesperson for the EU Commission tells MedWatch.
The expectations for Genmab's pipeline are too high, says Germany-based investment bank Berenberg Bank, which has changed its share recommendation as it cannot justify the current pricing.
The European Medicines Agency would use expedited procedures to approve new versions of the Covid-19 vaccines to address the omicron variant should the current ones prove insufficient to fight it off.
After more than two years leading the Danish pharmaceutical company, the board of directors and CEO Catherine Mazzacco have agreed she will step down.
Jacob Tolstrup, who has been an executive at the firm since 2012, will start in the role in the new year.
The European Centre for Disease Prevention and Control (ECDC) will now have more tools at its disposal to monitor and handle future epidemics. "Today's deal is state of the art monitoring," say EU sources.
Although inflation is generally rising, the medicine prices at Danish pharmacies have fallen by an average of 16 percent since January 2020. This means that in 2021, Danish patients have paid the least for their generic drugs in Europe.
Diabetes patient association Diabetesforeningen is unhappy with the proposed changes to the insulin reimbursement scheme, which it sees as a cost-cutting exercise that fails to take patients into consideration.
The general managers at Roche and Novo Nordisk in Denmark are calling for the EU pharma strategy to become more ambitious and visionary, and it should be enhanced in three areas in particular, write Roche’s Darine Ghanem and Novo Nordisk’s Kasper Bødker Mejlvang.
If it needs to, Bavarian Nordic will be able to keep pace with Moderna and Pfizer/Biontech and change its Covid-19 vaccine so it works against the Omicron variant.
A new, larger patient study has found that the capsule treatment reduces hospitalizations and deaths associated with Covid-19 to a far lesser degree than previously documented.
Carsten Stendevad has chosen to leave Novo Holdings' board as he has been given new investment responsibilities at the world's largest hedge fund, Bridgewater.
A number of pharmaceutical companies have started investigating how they can adapt their existing vaccines or design new ones to tackle the new Covid-19 variant, which is spreading rapidly.
The employee representative on the board of medtech company Ambu, Jakob Bønnelykke Kristensen, has sold 5,000 shares in the company for just under DKK 1m (USD 150,000).
Senior Manager, Global Regulatory Affairs CMC Senior Clinical Data Manager Director, Team Lead, Trial Management, Hematology 
Director Regulatory Affairs 
QA Specialist, GMP QA 
Regulatory documentation Specialist 
Senior Clinical Project Manager 
Procurement Manager 
VP, Head of CMC Pharmaceutical and Device Development 
Clinical Bioinformatician 
Nordic Field Sales Manager 
Global Stakeholder Partnership Manager Chemist for process development 
Senior Clinical Trial Manager Medical Director, Translational Medicine 
Application Manager (GxP Systems) 
KLIFO is looking for a talented and committed eTMF Manager for our Glostrup Office KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Join us! And start to impact healthcare through innovation 
QA Manager, QA Commercial Operations, Ascendis Pharma Manager, R&D & Global Quality Applications Medical Director Senior Director, Global Regulatory Lead CMC Stability Specialist Senior Manager/Associate Director Regulatory Affairs 
